Ginkgo Bioworks Holdings Inc vs Fabrinet — how do they compare? Ginkgo Bioworks Holdings Inc trades at $7.51 (market cap $505.73M), while Fabrinet trades at $554.32 (market cap $18.84B). The key difference: Fabrinet is far larger — about 37.3× Ginkgo Bioworks Holdings Inc's market cap, and Fabrinet is trading nearer its 52-week high, Ginkgo Bioworks Holdings Inc nearer its low. Which is the better fit depends on your goals.
| DNA | FN | |
|---|---|---|
Market Cap | $505.73M | $18.84B |
Sector | Health | Technology |
52-Week High | $16.14 | $746.47 |
52-Week Low | $5.48 | $277.04 |
Enterprise Value | $607.68M | $17.90B |
Trailing returns across standard periods
Latest headlines on both assets
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →Fabrinet provides advanced optical and electromechanical manufacturing services to original equipment manufacturers. It specializes in complex products for telecom, automotive, and medical industries.
Read more on FN →